CL2023000675A1 - [6-[(dietilamino)metil]naftalen-2-il]metil[4-(hidroxicarbamoil)fenil]carbamato de alta pureza - Google Patents

[6-[(dietilamino)metil]naftalen-2-il]metil[4-(hidroxicarbamoil)fenil]carbamato de alta pureza

Info

Publication number
CL2023000675A1
CL2023000675A1 CL2023000675A CL2023000675A CL2023000675A1 CL 2023000675 A1 CL2023000675 A1 CL 2023000675A1 CL 2023000675 A CL2023000675 A CL 2023000675A CL 2023000675 A CL2023000675 A CL 2023000675A CL 2023000675 A1 CL2023000675 A1 CL 2023000675A1
Authority
CL
Chile
Prior art keywords
methyl
hydroxycarbamoyl
naphthalen
diethylamino
carbamate
Prior art date
Application number
CL2023000675A
Other languages
English (en)
Inventor
Turchetta Stefano
Maurizio Zenoni Zenoni
Ullucci Elio
COCCIOLO Stefania
Berardi Giorgio
MAULUCCI Nakia
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of CL2023000675A1 publication Critical patent/CL2023000675A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/08Separation; Purification; Stabilisation; Use of additives
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/74Optical detectors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography

Abstract

(6-((dietilamino)metil)naftalen-2-il)metil(4-(hidroxicarbamoil)fenil)carbamato y/o las sales farmacéuticamente aceptables del mismo, preferiblemente clorhidrato, más preferiblemente hidrocloruro monohidrato de alta pureza, con una cantidad de cualquier impureza única desconocida igual o inferior al 0,10 % y con una pureza igual o superior al 99,6 %.
CL2023000675A 2019-03-06 2023-03-09 [6-[(dietilamino)metil]naftalen-2-il]metil[4-(hidroxicarbamoil)fenil]carbamato de alta pureza CL2023000675A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000003281A IT201900003281A1 (it) 2019-03-06 2019-03-06 Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza

Publications (1)

Publication Number Publication Date
CL2023000675A1 true CL2023000675A1 (es) 2023-12-11

Family

ID=66690827

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2021002302A CL2021002302A1 (es) 2019-03-06 2021-09-02 Proceso para preparar {6-[(dietilamino)metil]naftalen-2-il}metil [4-(hidroxicarbamoil) fenil]carbamato de alta pureza
CL2023000675A CL2023000675A1 (es) 2019-03-06 2023-03-09 [6-[(dietilamino)metil]naftalen-2-il]metil[4-(hidroxicarbamoil)fenil]carbamato de alta pureza

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2021002302A CL2021002302A1 (es) 2019-03-06 2021-09-02 Proceso para preparar {6-[(dietilamino)metil]naftalen-2-il}metil [4-(hidroxicarbamoil) fenil]carbamato de alta pureza

Country Status (14)

Country Link
US (2) US20220177421A1 (es)
EP (1) EP3891124A1 (es)
JP (1) JP2022527146A (es)
KR (1) KR20210137098A (es)
CN (4) CN116947703A (es)
AU (1) AU2020231702A1 (es)
CA (2) CA3129436A1 (es)
CL (2) CL2021002302A1 (es)
CO (1) CO2021011714A2 (es)
IL (1) IL284811A (es)
IT (1) IT201900003281A1 (es)
MX (1) MX2021010549A (es)
PE (1) PE20212321A1 (es)
WO (1) WO2020178776A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3120626B1 (fr) 2021-03-09 2023-11-24 Saint Gobain Dispositif de positionnement de feuilles de verre, installation de fabrication de vitrages comportant un tel dispositif et procédé pour piloter automatiquement le positionnement des feuilles de verre dans une telle installation
EP4230196A1 (en) 2022-02-21 2023-08-23 Som Innovation Biotech, S.A. Compounds for use in the treatment of dystrophinopathies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
ITMI20030063A1 (it) 2003-01-17 2004-07-18 Italfarmaco Spa Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.
IT1397912B1 (it) * 2010-01-28 2013-02-04 Chemi Spa Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.

Also Published As

Publication number Publication date
IT201900003281A1 (it) 2020-09-06
AU2020231702A1 (en) 2021-08-05
EP3891124A1 (en) 2021-10-13
CN113614066A (zh) 2021-11-05
CA3129436A1 (en) 2020-09-10
US20220177421A1 (en) 2022-06-09
CN113614066B (zh) 2023-08-29
US20230348368A1 (en) 2023-11-02
MX2021010549A (es) 2021-11-12
CA3230330A1 (en) 2020-09-10
CL2021002302A1 (es) 2022-05-06
WO2020178776A1 (en) 2020-09-10
CO2021011714A2 (es) 2021-10-29
WO2020178776A9 (en) 2021-06-24
PE20212321A1 (es) 2021-12-14
CN116947702A (zh) 2023-10-27
CN116947703A (zh) 2023-10-27
CN116947701A (zh) 2023-10-27
JP2022527146A (ja) 2022-05-31
KR20210137098A (ko) 2021-11-17
IL284811A (en) 2021-08-31

Similar Documents

Publication Publication Date Title
CL2023000675A1 (es) [6-[(dietilamino)metil]naftalen-2-il]metil[4-(hidroxicarbamoil)fenil]carbamato de alta pureza
TWD207835S (zh) 耳環
TWD205321S (zh) 耳環
ZA202006378B (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
PE20220502A1 (es) Compuestos utiles como inhibidores de cinasa
NO20040511L (no) Aminoisoxazolderivater som kinaseinhibitorer
EA201691428A1 (ru) Бициклические гетероциклические производные в качестве ингибиторов irak4
CY1120907T1 (el) Αντιμυκητιασικοι παραγοντες
PE20120516A1 (es) Inhibidor de la map cinasa p38
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
ECSP088258A (es) Inhibidores de serina proteasas
AR053169A1 (es) Metabolitos de n-2 (cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil) -2-metil -4-pi rimidinil] amino]-5-tiazol carboxamidas
EA200501009A1 (ru) Замещённые пирролопиразольные производные в качестве ингибиторов киназы
CR20190242A (es) Formas cristalinas de inhibidor de magl
TWD203907S (zh) 耳環
CL2020002252A1 (es) Formulación oftálmica.
AR111469A1 (es) Sal de un compuesto del derivado de aminopiridina, una forma cristalina de la misma, y un proceso para preparar la misma
DE60324014D1 (de) Heterocyclische verbindungen alsccr5-antagonisten
WO2014106800A3 (en) Substituted 2-amino pyrimidine derivatives as kinase inhibitors
EA202191286A1 (ru) Ингибитор 15-pgdh
TWD204812S (zh) 耳環
TWD215143S (zh) 扳手
CY1112718T1 (el) Ν- (2-υδροξυαιθυλ) -ν-μεθυλ-4- (κινολιν-8-υλ (1- (θειαζολ-4-υλμεθυλ) πιπεριδιν- 4 -υλιδενο) μεθυλ) βενζαμιδιο, η μεθοδος παρασκευης του καθως και η χρηση του για τη θεραπευτικη αγωγη πονου, αγχους και καταθλιψης
JOP20200133A1 (ar) طريقة لتحضير حمض (3s)-3-(4-كلورو-3-{[(2s،3r) -2-(4-كلورو فنيل) -4، 4، 4-ثلاثي فلورو-3-مثيل بيوتانويل] أمينو} فنيل) -3- بروبيل حلقي بروبانويك والشكل البلوري منه لاستخدامه كمركب فعال صيدلانياً
SG11201806974PA (en) Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereof